|
||
© The Rockefeller University Press,
0021-9525/2000//17 $5.00
The Journal of Cell Biology, Volume 149, Number 1,
, 2000 17-22
Brief Report |
Keratin-Dependent, Epithelial Resistance to Tumor Necrosis Factor-Induced Apoptosis
rgoshima{at}burnham-inst.org
Tumor necrosis factor (TNF) is a cytokine produced by macrophages and T lymphocytes that acts through two distinct receptors, TNFR1 (60 kD, CD120a) and TNFR2 (80 kD, CD120b), to affect cellular proliferation, differentiation, survival, and cell death. In addition to its proinflammatory actions in mucosal tissue, TNF is important for liver regeneration. Keratin 8 (K8) and keratin 18 (K18) form intermediate filaments characteristic of liver and other single cell layered, internal epithelia and their derivative cancers. K8-deficient (K8–) mice, which escape embryonic lethality, develop inflammatory colorectal hyperplasia, mild liver abnormalities, and tolerate hepatectomy poorly. We show that normal and malignant epithelial cells deficient in K8 and K18 are
100 times more sensitive to TNF-induced death. K8 and K18 both bind the cytoplasmic domain of TNFR2 and moderate TNF-induced, Jun NH2-terminal kinase (JNK) intracellular signaling and NF
B activation. Furthermore, K8– and K18– mice are much more sensitive to TNF dependent, apoptotic liver damage induced by the injection of concanavalin A. This moderation of the effects of TNF may be the fundamental function of K8 and K18 common to liver regeneration, inflammatory bowel disease, hepatotoxin sensitivity, and the diagnostic, persistent expression of these keratins in many carcinomas.
Key Words: cytoskeleton intermediate filament inflammatory bowel disease tumor necrosis factor receptor 2
© 2000 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
Multiple members of the TNFR family of receptors (TNFR1, Fas, DR3, TRAIL-R1, and TRAIL-R2) contain a death domain that nucleates an apoptotic signaling complex with binding of the adapter protein, FADD, activation of caspase 8 and downstream caspases that results in cell death (Ashkenazi and Dixit 1998). TNFR2 and other members of the TNF receptor family (LTβR, CD40, and CD30) lack a death domain, but also bind members of the TNF receptor-associated factors (TRAF) family. TRAF3 is proapoptotic (VanArsdale et al. 1997), whereas TRAF2 and TRAF5 may inhibit apoptosis. One mechanism of TNFR2 induction of apoptosis is through the induction of TNF, which then stimulates TNFR1 (Grell et al. 1999). TNF is also essential for liver regeneration (Yamada et al. 1997). Here, we present evidence for a key role for K8 and K18 in moderating the signaling and effects of TNF. This moderating effect provides epithelial cells with resistance to the apoptotic effects of TNF.
| Materials and Methods |
|---|
|
|
|---|
pGEX vectors containing the cytoplasmic domains of CD40, LTβR, HVEM, Fas, TNFR1, and TNFR2 were used for expressing and purifying the corresponding glutathione S-transferase (GST) fusion proteins (Mosialos et al. 1995). pGEX-Fas and pGEX-TNFR2 were gifts from Dr. Takaaki Sato (Columbia University, New York). GST fusion proteins were purified from Escherichia coli (A0202) bacteria after induction in 0.1 mM of isopropyl-β-D-thiogalactopyranoside for 3 h following the manufacturer's instructions (Pharmacia Biotech). GST fusion protein binding experiments were performed using 5 µg of each protein (Sato et al. 1995). K8 and K18 proteins were synthesized and K18 was cleaved with caspase 6 after coupled transcription and translation reactions as described previously (Caulin et al. 1997).
HR9 cells on coverslips were fixed with cold methanol and were then processed for immunostaining using rabbit antiserum #18 for K18 (Oshima 1981), anti-K18 mAb CK5 (Sigma Chemical Co.), monoclonal rat anti–human TNFR2 (Genzyme Diagnostics), FITC-labeled goat anti–rat IgG (Jackson ImmunoResearch), and rhodamine-labeled goat anti–rabbit (Sigma Chemical Co.). Cells were visualized with a BioRad MRC 1024 confocal microscope. Figures were generated with the use of Adobe Photoshop software. Single confocal sections were used to visualize colocalized proteins.
Jun N-terminal kinase (JNK) activity was assessed as described (Cavigelli et al. 1995). HR9 and HR-7 cells were transfected with 1 µg of pCMV-M2-FLAG-JNK1 by the calcium phosphate precipitation method. 48 h after the addition of the DNA, the cells were treated with 10 ng/ml of TNF for the indicated times and assayed for JNK activity. Film signals were quantified using the NIH Image software. Reporter genes for NF
B (NF
B-luc) and Ets (E18-luc) were transfected and assayed as described (Galang et al. 1996). The human β-actin promoter-driven LacZ gene was included for normalization of transfection efficiency. The cells were treated with 10 ng/ml of TNF for 6 h, 48 h after the addition of DNA. Luciferase and β-galactosidase activity was determined with the Dual-Light commercial kit (Tropix) with an EGG Berthold luminometer. Relative luciferase activity was normalized to the β-galactosidase activity and expressed as a percentage of the maximum activity.
The K8– mice were in an FVB/N genetic background (Baribault et al. 1993, Baribault et al. 1994). The K18– mice (Magin et al. 1998) had a mixed background (129/Sv,MF1,FVB/N). Littermates without targeted keratin alleles were used as controls. Male mice (12–14-wk-old) were fasted for 24 h before i.v. injection of concanavalin A (ConA; 30 mg/kg), dissolved in 200 µl of pyrogen-free saline (Tiegs et al. 1992). 8 h after injection, blood was collected by cardiac puncture. Serum was frozen at –85°C. The activity of alanine aminotransferase and aspartate aminotransferase was measured with a commercial kit (Sigma Chemical Co.) according to the directions of the manufacturer. Livers were fixed in 10% neutral-buffered formalin and embedded in paraffin. 5-µm thick sections were stained with hematoxylin and eosin or for detection of apoptosis. Apoptosis was detected with the ApopTag kit (Oncor) according to the instructions of the manufacturer.
| Results |
|---|
|
|
|---|
|
|
|
If modulation of apoptosis is mediated by the direct interaction of K8 and K18 with TNF receptors, the presence of K8 and K18 might affect TNF signaling pathways. Treatment of HR9 cells with TNF (10 ng/ml) results in a modest increase in activity of JNK that reaches a maximum 10 min after ligand exposure and stays constant for up to 45 min (Fig. 4 a). However, HR-7 cells, with disrupted K8 and K18 filaments, responded to TNF by increasing the level and duration of JNK activity. The maximum induction was 30 min after TNF exposure. Quantitation indicated that TNF induced a maximum 1.5-fold activation of JNK in HR9 cells, whereas the activation in HR-7 cells was more than threefold (Fig. 4 b).
|
B and Ets transcription factors. NF
B activity was higher after TNF treatment in HR-7 than HR9 cells (Fig. 4 c). In comparison to HR9 cells treated with 10 ng/ml TNF, tenfold less TNF was needed to elicit similar NF
B activity in HR-7 cells. In contrast to NF
B activity, Ets transcriptional activities were similar in both cell types (Fig. 4 d). These results indicate that TNF-mediated NF
B activation is moderated by the presence of K8 and K18. Both the JNK and NF
B responses indicate that K8 and K18 may moderate TNF-initiated intracellular signaling. To test the functional significance of K8 and K18 in cell death that is mediated by membrane receptors in vivo, we used the mouse model of ConA-induced liver damage (Tiegs et al. 1992). ConA-induced liver apoptosis is mediated by activated T cells through TNF (Mizuhara et al. 1994). Both TNFR1 and TNFR2 are required for liver injury (Kusters et al. 1997). We injected ConA into wild-type, K8–, and K18– mice. Both strains of keratin-deficient mice were more sensitive to liver damage initiated by ConA (Fig. 5, a and b). Serum levels of both liver transaminases were two to three times higher in treated K8– or K18– mice than wild-type littermates (P < 0.028). Whereas K8– mice have slightly elevated, but nonpathological, levels of these enzymes in untreated animals (Baribault et al. 1994), the levels caused by ConA were 50–100 times higher than untreated mice, reflective of the massive liver damage.
|
In summary, decreasing levels of K8 and K18 in cultured epithelial cells increases their cellular sensitivity to killing by TNF. K8 and K18 bind the cytoplasmic domains of TNFR2, colocalize with TNFR2 within cells, and moderate the TNF-dependent activation of JNK and the NF
B transcription factor. Mice without K8 or K18 are more sensitive to TNF-mediated apoptotic liver damage.
| Discussion |
|---|
|
|
|---|
The disruption or absence of keratins in the liver leads to mild hepatitis and increased sensitivity to the hepatotoxin acetaminophen (Baribault et al. 1994; Ku et al. 1996). Based on an increased sensitivity of K8– hepatocytes to perfusion, microcystin exposure and partial hepatectomy, K8 and K18 have been suggested to be necessary for the structural integrity of hepatocytes (Ku et al. 1995; Loranger et al. 1997; Toivola et al. 1998). However, TNF acts as both a growth factor and apoptotic stimulus in liver. It is expressed in liver during acute and chronic liver damage (Czaja et al. 1989) and after exposure to high levels of acetaminophen (Blazka et al. 1995). Neutralizing anti-TNF antibodies significantly reduce liver injury caused by acetaminophen, but inhibit liver regeneration after partial hepatectomy (Akerman et al. 1992; Blazka et al. 1996). The increased sensitivity of K8– liver cells to TNF may be the basis for poor tolerance of partial hepatectomy and poor survival of explanted hepatocytes. A distinctive feature of K8, K18, and K19 is persistent or induced expression in carcinomas in comparison to other keratins. The keratin-dependent resistance to TNF may be the selective advantage responsible for the persistence of K8 and K18 expression in carcinoma cells. Resistance of epithelia to apoptosis is likely important during common inflammatory responses.
| Acknowledgments |
|---|
This work was supported by grants to R.G. Oshima (National Cancer Institute, CA42302), C.F. Ware (National Cancer Institute, CA69381; and the American Cancer Society, IM663), and T.M. Magin (Deutsche Forschungsgemeinschaft, SFB 284).
Submitted: 11 January 2000
Revised: 21 February 2000
Accepted: 22 February 2000
Abbreviations used in this paper: CHX, cycloheximide; ConA, concanavalin A; GST, glutathione S-transferase; JNK, Jun NH2-terminal kinase; K8, keratin 8; K18, keratin 18; K8–, homozygous null Krt2-8 targeted mutation; K18–, homozygous null Krt1-18 targeted mutation; TNF, tumor necrosis factor; TNFR1, tumor necrosis factor receptor 1; TNFR2, tumor necrosis factor receptor 2; TRAF, TNF receptor associated factors.
| References |
|---|
|
|
|---|
Akerman P., Cote P., Yang S.Q., McClain C., Nelson S., Bagby G.J. & Diehl A.M.. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy, Am. J. Physiol., 263, 1992, G579–G585.[Medline]
Ashkenazi A. & Dixit V.M.. Death receptorssignaling and modulation, Science, 281, 1998, 1305–1308.
Baribault H., Price J., Miyai K. & Oshima R.G.. Mid-gestational lethality in mice lacking keratin 8, Genes Dev., 7, 1993, 1191–1202.
Baribault H., Penner J., Iozzo R.V. & Wilson-Heiner M.. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice, Genes Dev., 8, 1994, 2964–2973.
Blazka M.E., Wilmer J.L., Holladay S.D., Wilson R.E. & Luster M.I.. Role of proinflammatory cytokines in acetaminophen hepatotoxicity, Toxicol. Appl. Pharmacol., 133, 1995, 43–52.[Medline]
Blazka M.E., Elwell M.R., Holladay S.D., Wilson R.E. & Luster M.I.. Histopathology of acetaminophen-induced liver changesrole of interleukin 1 alpha and tumor necrosis factor alpha, Toxicol Pathol, 24, 1996, 181–189.
Braegger C.P., Nicholls S., Murch S.H., Stephens S. & MacDonald T.T.. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation, Lancet, 339, 1992, 89–91.[Medline]
Caulin C., Salvesen G.S. & Oshima R.G.. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial apoptosis, J. Cell Biol., 138, 1997, 1379–1394.
Cavigelli M., Dolfi F., Claret F.-X. & Karin M.. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation, EMBO (Eur. Mol. Biol. Organ.) J., 14, 1995, 5957–5964.[Medline]
Czaja M.J., Weiner F.R., Flanders K.C., Giambrone M.A., Wind R., Biempica L. & Zern M.A.. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis, J. Biol. Chem., 108, 1989, 2477–2482.
Fuchs E. & Weber K.. Intermediate filamentsstructure, dynamics, function, and disease, Annu. Rev. Biochem., 63, 1994, 345–382.[Medline]
Galang C.K., Garcia-Ramirez J.J., Solski P.A., Der C.J., Neznanov N.N., Oshima R.G. & Hauser C.A.. Oncogenic neu/ErbB-2 increases Ets, AP-1, and NF
B-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation, J. Biol. Chem., 271, 1996, 7992–7998.
Green L.M., Reade J.L. & Ware C.F.. Rapid colorimetric assay for cell viabilityapplication to the quantitation of cytotoxic and growth inhibitory lymphokines, J. Immunol. Methods, 70, 1984, 257–268.[Medline]
Grell M., Zimmermann G., Gottfried E., Chen C.-M., Grunwald U. & Huang D.C.S.. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30a role for TNF-R1 activation by endogenous membrane-anchored TNF, EMBO (Eur. Mol. Biol. Organ.) J., 18, 1999, 3034–3043.[Medline]
Ku N.-O., Michie S., Oshima R.G. & Omary M.B.. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant, J. Cell Biol., 131, 1995, 1303–1314.
Ku N.-O., Michie S., Soetikno R., Resurreccion E., Oshima R.G. & Omary M.B.. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant, J. Clin. Invest., 98, 1996, 1034–1046.[Medline]
Kulesh D.A., Cecena G., Darmon Y.M., Vasseur M. & Oshima R.G.. Post-translational regulation of keratinsdegradation of unpolymerized mouse and human keratins 18 and 8, Mol. Cell. Biol., 9, 1989, 1553–1565.
Kusters S., Tiegs G., Alexopoulou L., Pasparakis M., Douni E., Kunstle G., Bluethmann H., Wendel A., Pfizenmaier K., Kollias G. & Grell M.. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis, Eur. J. Immunol., 27, 1997, 2870–2875.[Medline]
Leist M., Gantner F., Bohlinger I., Tiegs G., Germann P.G. & Wendel A.. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models, Am. J. Pathol., 146, 1995, 1220–1234.[Abstract]
Loranger A., Duclos S., Grenier A., Price J., Wilson-Heiner M., Baribault H. & Marceau N.. Simple epithelium keratins are required for maintenance of hepatocyte integrity, Am. J. Pathol., 151, 1997, 1673–1683.[Abstract]
Magin T.M., Schroder R., Leitgeb S., Wanninger F., Zatloukal K., Grund C. & Melton D.W.. Lessons from keratin 18 knockout miceformation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates, J. Cell Biol., 140, 1998, 1441–1451.
Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., Satoh S., Niwa M., Senoh H. & Fujiwara H.. T cell activation-associated hepatic injurymediation by tumor necrosis factors and protection by interleukin 6, J. Exp. Med., 179, 1994, 1529–1537.
Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C. & Kieff E.. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family, Cell, 80, 1995, 389–399.[Medline]
Omary M.B. & Ku N.O.. Intermediate filament proteins of the liveremerging disease association and functions, Hepatology, 25, 1997, 1043–1048.[Medline]
Oshima R.G.. Identification and immunoprecipitation of cytoskeletal proteins from murine extra-embryonic endodermal cells, J. Biol. Chem., 256, 1981, 8124–8133.
Oshima R.G., Baribault H. & Caulin C.. Oncogenic regulation and function of keratin 8 and 18, Cancer Metastasis Rev., 15, 1996, 445–471.[Medline]
Sarria A.J., Nordeen S.K. & Evans R.M.. Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network, J. Biol. Chem., 111, 1990, 553–565.
Sartor R.B.. Cytokines in intestinal inflammationpathophysiological and clinical considerations, Gastroenterology, 106, 1994, 533–539.[Medline]
Sato T., Irie S., Kitada S. & Reed J.C.. FAP-1A protein tyrosine phosphatase that associates with fas, Science, 268, 1995, 411–415.
Tiegs G., Hentschel J. & Wendel A.. A T cell-dependent experimental liver injury in mice inducible by concanavalin A, J. Clin. Invest., 90, 1992, 196–203.[Medline]
Toivola D.M., Omary M.B., Ku N., Peltola O., Baribault H. & Eriksson J.E.. Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity, Heptology., 28, 1998, 116–128.
van Dullemen H.M., van Deventer S.J., Hommes D.W., Bijl H.A., Jansen J., Tytgat G.N. & Woody J.. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2), Gastroenterology, 109, 1995, 129–135.[Medline]
VanArsdale T.L., VanArsdale S.L., Force W.R., Walter B.N., Mosialos G., Kieff E., Reed J.C. & Ware C.F.. Lymphotoxin-β receptor signaling complexrole of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kB, Proc. Natl. Acad. Sci. USA, 94, 1997, 2460–2465.
Weiss T., Grell M., Hessabi B., Bourteele S., Muller G., Scheurich P. & Wajant H.. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80, J. Immunol., 158, 1997, 2398–2404.[Abstract]
Yamada Y., Kirillova I., Peschon J.J. & Fausto N.. Initiation of liver growth by tumor necrosis factordeficient liver regeneration in mice lacking type I tumor necrosis factor receptor, Proc. Natl. Acad. Sci. USA, 94, 1997, 1441–1446.
Related Article
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|